Joshua DeTillio - 28 Jun 2024 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role
Chief Operating Officer
Signature
/s/ Joshua DeTillio
Issuer symbol
NUTX
Transactions as of
28 Jun 2024
Net transactions value
$0
Form type
4
Filing time
28 Jun 2024, 11:55:48 UTC
Previous filing
13 Jun 2024
Next filing
21 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUTX Restricted Stock Unit Award $0 +63,750 $0.000000 63,750 28 Jun 2024 Common Stock 63,750 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
F2 Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. DeTillio, dated June 28, 2024, the 63,750 RSUs granted to Mr. DeTillio will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.